Abstract
Long-term, open-label safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: final report of a 4-year study
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
